Recent advances in technology allow us to consider the epigenome as well as the genome of a tumour on an individual level. These advances, in combination with high throughput technologies, are leading to rapid advances in the development of epigenetic biomarkers and novel therapeutic targets.
Termin:
08.11.2015 - 11.11.2015
Veranstaltungsort:Harnack House - The Conference Centre of the Max Planck Society
Informationen im Web:atnd.it/27171-0 |
Veranstalter:European Association for Cancer ResearchSir Colin Campbell Building NG7 2TU Nottingham Frau Caroline Moulins Tel.: 004401159515066 E-Mail: caroline.moulins@nottingham.ac.uk |
Supplements
Supplements OrphanAnesthesia


